(RTTNews) - Taro Pharmaceuticals U.S.A., Inc. has recalled one lot of corticosteroid Clobetasol Propionate in the form of ointment for the potential presence of Ralstonia pickettii bacteria, the U.S.
MALVERN, Pa.--(BUSINESS WIRE)--The announcement was made today, at the 15 th annual Maui Derm Conference, that Impoyz Cream demonstrated efficacy early, with 14.2% of Impoyz patients achieving ...
Dr. Reddy’s Laboratories announced that the Food and Drug Administration (FDA) has approved Impoyz (clobetasol propionate) Cream 0.025%, formerly DFD-06, for the treatment of moderate to severe plaque ...
DUBLIN, March 9, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it has launched a generic version of Fougera's Temovate® ...
To date, the Company has not received reports of adverse events related to this recall. Taro Pharmaceuticals has issued a voluntary recall of 1 lot of Clobetasol Propionate Ointment USP, 0.05%, 60g ...
HYDERABAD, India & PRINCETON, N.J. & MALVERN, Pa.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), through its wholly owned ...
BUENA, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results